| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |